<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Coffey EL</submitter><funding>NCATS NIH HHS</funding><funding>NIH Special Emphasis Research Career Award</funding><funding>NIH Office of the Director Special Emphasis Research Career Award</funding><funding>NIH HHS</funding><funding>the Intramural Research Program of the National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland</funding><funding>Division of Comparative Medicine, Office of Research Infrastructure Programs</funding><funding>NIH National Center for Advancing Translational Sciences</funding><pagination>198</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10970956</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(3)</volume><pubmed_abstract>Pet dogs are a valuable natural animal model for studying relationships between primary immunodeficiencies and susceptibility to &lt;i>Pneumocystis&lt;/i> and other opportunistic respiratory pathogens. Certain breeds, such as the Cavalier King Charles Spaniel, are over-represented for &lt;i>Pneumocystis&lt;/i> pneumonia (PCP), suggesting the presence of a primary immunodeficiency in the breed. Here, we report the discovery of a &lt;i>CARMIL2&lt;/i> nonsense variant in three Cavalier King Charles Spaniel dogs with either PCP (n = 2) or refractory &lt;i>Bordetella&lt;/i> pneumonia (n = 1). &lt;i>CARMIL2&lt;/i> encodes a protein that plays critical roles in T-cell activation and other aspects of immune function. Deleterious &lt;i>CARMIL2&lt;/i> variants have recently been reported in human patients with PCP and other recurrent </pubmed_abstract><journal>Journal of fungi (Basel, Switzerland)</journal><pubmed_title>A Novel &lt;i>CARMIL2&lt;/i> Immunodeficiency Identified in a Subset of Cavalier King Charles Spaniels with &lt;i>Pneumocystis&lt;/i> and &lt;i>Bordetella&lt;/i> Pneumonia.</pubmed_title><pmcid>PMC10970956</pmcid><funding_grant_id>UL1 TR002494</funding_grant_id><funding_grant_id>1 K01 OD027058</funding_grant_id><funding_grant_id>KL2 TR002492</funding_grant_id><funding_grant_id>K01 OD027058</funding_grant_id><funding_grant_id>K01 OD019912</funding_grant_id><funding_grant_id>K01OD027058</funding_grant_id><funding_grant_id>UL1TR002494</funding_grant_id><funding_grant_id>K01OD019912</funding_grant_id><pubmed_authors>Granick MN</pubmed_authors><pubmed_authors>Minor KM</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Kovacs JA</pubmed_authors><pubmed_authors>Cisse OH</pubmed_authors><pubmed_authors>Cullen JN</pubmed_authors><pubmed_authors>Sukura A</pubmed_authors><pubmed_authors>Friedenberg SG</pubmed_authors><pubmed_authors>Weissenbacher-Lang C</pubmed_authors><pubmed_authors>Nadeau JC</pubmed_authors><pubmed_authors>Graham AM</pubmed_authors><pubmed_authors>Jacobs CM</pubmed_authors><pubmed_authors>Furrow E</pubmed_authors><pubmed_authors>Branson KC</pubmed_authors><pubmed_authors>Coffey EL</pubmed_authors><pubmed_authors>Danesi P</pubmed_authors><pubmed_authors>Branson NK</pubmed_authors><pubmed_authors>Blasi B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Novel &lt;i>CARMIL2&lt;/i> Immunodeficiency Identified in a Subset of Cavalier King Charles Spaniels with &lt;i>Pneumocystis&lt;/i> and &lt;i>Bordetella&lt;/i> Pneumonia.</name><description>Pet dogs are a valuable natural animal model for studying relationships between primary immunodeficiencies and susceptibility to &lt;i>Pneumocystis&lt;/i> and other opportunistic respiratory pathogens. Certain breeds, such as the Cavalier King Charles Spaniel, are over-represented for &lt;i>Pneumocystis&lt;/i> pneumonia (PCP), suggesting the presence of a primary immunodeficiency in the breed. Here, we report the discovery of a &lt;i>CARMIL2&lt;/i> nonsense variant in three Cavalier King Charles Spaniel dogs with either PCP (n = 2) or refractory &lt;i>Bordetella&lt;/i> pneumonia (n = 1). &lt;i>CARMIL2&lt;/i> encodes a protein that plays critical roles in T-cell activation and other aspects of immune function. Deleterious &lt;i>CARMIL2&lt;/i> variants have recently been reported in human patients with PCP and other recurrent </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-09T10:48:08.549Z</modification><creation>2025-05-31T23:11:56.305Z</creation></dates><accession>S-EPMC10970956</accession><cross_references><pubmed>38535207</pubmed><doi>10.3390/jof10030198</doi></cross_references></HashMap>